🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

GeneDx Holdings Corp.

WGS Healthcare
$101.1 $-3.85 (-3.67%)
Market Cap: $3.02 B
Gurus Holding
6
Popularity Rank
#1387
% of Shares Held
6.73%
Net Activity (Q2 2026)
+$18.59 M

Guru Ownership Trend

Guru Analysis for GeneDx Holdings Corp. (WGS)

GeneDx Holdings Corp. (WGS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $202.95 M.

Top institutional holders include Catherine Wood and Chuck Royce.

Institutional sentiment is currently Bullish. This is evidenced by a $18.59 M net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who increased their stake by 224.5%. Conversely, Chuck Royce reduced exposure by 20.2%.

Key Holders

Top 5 by Value

$110.54 M
$7.7 M
$6.68 M
$3.42 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$30.41 M
Total Buy Value
New Buys 1
Additions 4
-$11.82 M
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
2
Net Buyers
5

FAQs for GeneDx Holdings Corp. (WGS)

Major holders include Catherine Wood ($110.54 M), Chuck Royce ($7.7 M), Paul Tudor Jones ($7.47 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 2.01 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $18.59 M, with 5 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited WGS. The total reported sell value was $11.82 M.

Yes, 1 managers opened new positions in WGS, and 4 increased their existing holdings. The total reported buy value was $30.41 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.72% Add 21.6% 1,610,189 $110.54 M Q2 2026
0.06% Reduce -20.2% 112,136 $7.7 M Q2 2026
0.01% Add 224.5% 108,839 $7.47 M Q2 2026
0.01% Add 28.4% 97,300 $6.68 M Q2 2026
0.02% New Buy 49,800 $3.42 M Q2 2026
0.00% Add 58.6% 29,172 $2 M Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form